Pembrolizumab,Gemcitabine,Cisplatin
Merck
['key,note,966', 'key,note,45', 'pembro']
hear about juan valle's work on the phase 3 keynote-966 study investigating health-related quality of life of pembrolizumab vs placebo for #biliarytractcancer at 3:45pm at #asco23: #crukfunded 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK